Importance of stabilization of the mitral annulus in mitral valve repair  by Szentkirályi, István et al.
severity—proximal isolated stenoses ver-
sus multiple stenoses with distal vessel in-
volvement—are features of coronary artery
disease that strongly influence surgical
strategy, complexity of the operation, and
prognosis. Moreover, the quality of coro-
nary vessels and graft availability and qual-
ity determine the completeness of the
revascularization and its durability. With
the matching method adopted by Brown
and colleagues,1 these data are lost to the
analysis, making it impossible to evaluate
any effects on the higher perioperative
and long-term mortalities observed in the
bioprosthesis group. Higher mortality
could be related to an unfavorable preoper-
ative status. In that case, the surgeons who
performed the operations may have shown
good clinical judgment, implanting bio-
prostheses in patients with poor prognosis.
Moreover, there are no data on prosthesis
sizes, effective orifice areas, and the inci-
dence of patient–prosthesis mismatch, all
of which could influence long-term results.
In conclusion, Brown and colleagues de-
serve commendation for the insights from
their interesting study. Nevertheless, ex-
treme caution should be exercised in sup-
porting or questioning existing clinical
guidelines in response to potentially biased
retrospective studies.
Aldo Cannata, MD
Claudio Francesco Russo, MD
Corrado Taglieri, MD
Angelo De Gasperis Department of Cardiac
Surgery Niguarda Ca` Granda Hospital
Milan, Italy
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Reply to the Editor:
Drs Cannata, Russo, and Taglieri com-
mented on our results and the possible
impact of selection bias, which is present
in all observational surgical series. We
matched patients and used multivariate anal-
yses, but it is impossible to determine
whether this has accounted for all possible
confounders. We agree that only randomiza-
tion can distribute unmeasured covariates
evenly between groups.
A question was raised regarding the
extent of coronary artery disease. We
used coronary artery bypass grafting as
a surrogate for coronary artery disease,
and the mean numbers of grafts per patient
were 1.0 6 1.3 in the mechanical aortic
valve group and 1.0 6 1.2 in the biopros-
thetic aortic valve group (P 5 .86). We
performed an analysis of survival of pa-
tients undergoing aortic valve replacement
with and without coronary artery bypass
grafting (Figure 1). The survival benefit
we observed with a mechanical aortic
valve appears, however, to be independent
of the presence of coronary artery disease
in our multivariate model, as shown in
Table 5 of our original article.1
Our finding of a survival benefit in the
mechanical aortic valve group was surpris-
ing, and we have hypothesized that one
possible explanation would be patient–pros-
thesis mismatch. We do not have the effec-
tive orifice area data available for this
study group. We have, however, included
information regarding body surface area
and body mass index, size of prosthesis,
and the incidence of aortic root enlargement
in each group (see Table 1 in our original ar-
ticle). In general, surgeons at our clinic
perform aortic root enlargement to accom-
modate a larger prostheses in any patient
who is at risk for patient–prosthesis mis-
match.2
We believe that current guidelines are
generally appropriate for mechanical or bio-
prosthetic valve selection. Our primary
concern is with the growing trend toward
placing bioprosthetic aortic valves in youn-
ger patients. All observational (retrospective
or prospective) studies are unable to elimi-
nate the potential impact of patient selection
bias; however, this investigation adds equi-
poise.
Morgan Brown, MD
Hartzell Schaff, MD
Division of Cardiovascular Surgery, Mayo
Clinic, Rochester, MN
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Figure 1. Survivals in mechanical aortic valve (Mech V) and bioprosthetic aortic valve
(BPV) groups according to presence or absence of coronary artery disease, as indicated
by coronary artery bypass grafting (CABG).
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Letters to the EditorImportance of stabilization of
the mitral annulus in mitral valve
repair
To the Editor:
We read with great interest the article of
Flameng and coauthors1 about their expe-
riences with mitral valve repair in Barlow
disease and fibroelastic deficiency. They
found that not using annuloplasty ring
in mitral valve repair is a risk factor for
recurrent mitral valve regurgitation. We
Reply to the Editor:
I thank Szentkira´lyi, Pe´terffy, and Galajda
for their interest in our study on the durabil-
ity of mitral valve repair in Barlow disease.
The point they try to make in their letter is
that mitral annuloplasty in myxoid mitral
valve degeneration does not necessarily
have to be a ring annuloplasty. This might
be correct; who knows?
The problem is that, nowadays, when
you make a statement, hard data are required
to convince the medical and scientific com-
munity to agree with you. In our study on
the recurrence of mitral valve regurgitation
after successful repair of Barlow disease
and fibroelastic degeneration, we presented
and analyzed extensive preoperative, intrao-
perative, and postoperative data, including
long-term echocardiographic follow up. In
our study, patients received either a ring an-
nuloplasty or no annuloplasty at all. We did
not study any other form of annuloplasty,
and therefore it would not be correct to
draw such a general conclusion as, ‘‘Lack
of stabilization of the mitral annulus in-
creases the risk of recurrent mitral valve
regurgitation.’’ To advocate this statement,
one should test every possible form of
annuloplasty and compare them all with
no annuloplasty. In their own experience,
Szentkira´lyi, Pe´terffy, and Galajda mention
that some materials used for suture annulo-
plasty, such as polypropylene and polyester
sutures, cause recurrent regurgitation. Is
this not why the annuloplasty ring was
developed?
Before we conclude that ‘‘Lack of stabi-
lization of the mitral annulus increases the
risk of recurrent mitral valve regurgitation,’’
I invite Szentkira´lyi, Pe´terffy, and Galajda
to analyze their data on suture annuloplasty
in a scientific way and compare them with
results of repair procedures without annulo-
plasty, rather than relying on their own
experience, even with several hundred pa-
tients. I am well aware of the importance
of personal experiences of renowned sur-
geons such as our Hungarian colleagues,
and I appreciate the opportunity to share
these experiences. Before introducing a con-
cept into current praxis, however, I prefer
data-based, scientific proof.
W. Flameng, MD, PhD
Cardiac Surgery
Department of Cardiovascular Diseases
Katholieke Universiteit Leuven
Leuven, Belgium
doi:10.1016/j.jtcvs.2008.06.019
Questions on the angular
(Gothic) arch configuration and
its applicability after type I
aortic dissection repair
To the Editor:
I enjoyed the recent article ‘‘Angular
(Gothic) Aortic Arch Leads to Enhanced
Systolic Wave Reflection, Central Aortic
Stiffness, and Increased Left Ventricular
Mass Late After Aortic Coarctation Repair:
Evaluation With Magnetic Resonance Flow
Mapping,’’ by Ou and associates1 in a recent
issue of the Journal.1 Why were patients
Letters to the Editoragree completely that the mitral annulus
should be supported somehow, but our
experience suggests that suture annulo-
plasty gives good results without any
ring.
After our initial experience with suture
annuloplasty, published 8 years ago,2 we
performed several hundred mitral repairs
without annuloplasty rings and with good
early and midterm results. There are two
important factors in achieving a good
result with this method. The first is the
suture material. Both polypropylene
(Prolene; Ethicon, Inc, Somerville, NJ)
and polyester (Ethibond; Ethicon) sutures
were not reliable. Prolene was too elastic,
and in some cases the 3-0 Prolene thread
elongated, causing redilatation of the mi-
tral annulus. In a few cases, the Prolene
suture ruptured, causing recurrent mitral
regurgitation. Ethibond was difficult to
use in achieving proper and equal tensions
on the suture line and adequate shortening
of the annulus. We had superior ex-
periences with expanded polytetrafluoro-
ethylene (Gore-Tex; W. L. Gore &
Associates, Inc, Flagstaff, Ariz) sutures,
as also reported by others.3 The other im-
portant factor is that the sutures be placed
properly into the annulus. Neither sutures
in the left atrium in the vicinity of the an-
nulus nor sutures in the proximal parts of
the valve cusps give good results. This
should hold true even with ring annulo-
plasty.
Suture annuloplasty actually has advan-
tages relative to ring annuloplasty. Trans-
valvular gradient is significantly lower and
mitral valve area is significantly larger,
without differences in mitral regurgitation.4
The mitral annulus has a natural flexibility,
which results a 26% dilatation in diastole.5
The natural flexibility of the mitral annulus
is conserved with suture annuloplasty.
Suture annuloplasty is also a simpler and
much cheaper method of achieving stability
of the mitral annulus.
In our experience, if mitral repair is done,
mitral annuloplasty should be performed,
evenif theannulus isnot significantlydilated.
It is not absolutely necessary to use an annu-
loplasty ring, as Flameng and coworkers rec-
ommend1; suture annuloplasty can give
a good result as well. Their statement that
‘‘[N]onuse of annuloplasty ring is a risk fac-
tor for recurrent mitral valve regurgitation’’
would be true only if the comparison
included suture annuloplasty as well. Wehave not compared suture annuloplasty
with annuloplasty rings, but in accordance
with our experience, we would recommend
the following conclusion instead: ‘‘Lack of
stabilization of the mitral annulus increases
the risk of recurrent mitral valve regurgita-
tion.’’
Istva´n Szentkira´lyi, MD
A´rpa´d Pe´terffy, MD, PhD
Zolta´n Galajda, MD, PhD
Department of Cardiac Surgery
Institution of Cardiology
University of Debrecen, Medical and Health
Science Centre
Debrecen, Hungary
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